Bayer Licenses Senesco Technology
Senesco’s technology has initiated preclinical research to trigger or delay cell death in mammals (apoptosis). It’s potential for agricultural biotechnology has yet to be unlocked.
Senesco’s technology has initiated preclinical research to trigger or delay cell death in mammals (apoptosis). It’s potential for agricultural biotechnology has yet to be unlocked.